Technology News and Research

RSS

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc., today announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference.

29 Sep 2010

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.

29 Sep 2010

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced an extension of a seven year partnership with St. Vincent's HealthCare (SVHC) to further enhance the hospital's patient education initiatives. The health system will utilize TeleHealth's technology in St. Vincent's Medical Center and new addition, St. Luke's Hospital.

29 Sep 2010

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Ligon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray screening platform (SMM) to discover potential first-in-class drug candidates for new disease targets.

29 Sep 2010

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

Quick-Med Technologies, Inc.a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today its NIMBUS and Stay Fresh antimicrobial technologies will be highlighted at the 2010 Clinical Symposium on Advances in Skin and Wound Care, to be held in Orlando, Florida from September 30 – October 3, 2010.

29 Sep 2010

NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.

29 Sep 2010

Researchers primed to contribute next phase in search and discovery: Elsevier survey

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today released highlights from a new survey that reveals researchers around the globe are not only ready for the next phase in search and discovery, but also prepared to actively contribute to making it a reality.

29 Sep 2010

Sysmex to supply medical hematology analyzers to USAMMA

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced that the company has been awarded a BPA Equipment purchase contract agreement. The contract was issued by USA Medical Research ACQ Activity for the U.S. Army Medical Material Agency (USAMMA).

From Sysmex America, Inc. 29 Sep 2010

Inability to access EMRs at time of need a prime concern among patients

As the healthcare industry rushes to implement electronic medical records (EMRs) in order to increase efficiency and prevent errors, data shows that less than 1 in 10 Americans utilize electronic records. However, when asked about their primary concerns regarding medical records, patients' top response is that they won't be able to access their records when they need them.

29 Sep 2010

New computer program to help young adults manage mental illness

While many young adults will share the details of their daily lives with dozens - sometimes hundreds - of friends on Facebook, communicating with their health care providers about mental illness is another story.

29 Sep 2010

ANDalyze sensor/Fluorimeter platform solution introduced in China and Australia

ANDalyze sensor/Fluorimeter platform solution for simplifying the on-site testing and analysis of water for heavy metal contamination is now being sold in China and Australia as a replacement to more time consuming testing methods such as electrochemical and reagent testing methods that require significant training.

29 Sep 2010

African-American lung cancer patients with EGFR mutation respond better to erlotinib therapy

African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

29 Sep 2010

Circulating tumor cells may be promising alternative for tumor biopsies

Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

29 Sep 2010

CAP cells produce high virus titers upon influenza strain infection

CEVEC Pharmaceuticals, the developer of an extremely potent protein expression system based on human CAP cells, announced today that CAP cells produce high virus titers upon infection with influenza strains. The virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine production.

29 Sep 2010

Crescendo Biologics successfully delivers triple knockout mice

Crescendo Biologics Limited today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all functionally silenced by large-scale genomic deletion.

29 Sep 2010

BAC completes feasibility study on CaptureSelect affinity ligands for Genmab

BAC BV, the leading provider of antibody-based affinity purification technology, today announced that it successfully completed a feasibility study in its collaboration with Genmab A/S (Copenhagen, Denmark), an international biotechnology company developing human antibody therapeutics for the potential treatment of cancer.

29 Sep 2010

Scientists develop NIA assay to determine drug's differential effects in tumor cells

A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.

29 Sep 2010

New RTCA Cardio Instrument monitors real-time cardiomyocyte beating and cellular events

Roche announced today that it had launched the RTCA Cardio Instrument, the latest member of the xCELLigence product family. The RTCA Cardio Instrument is a medium throughput cell analyzer that utilizes impedance readings to monitor cardiac beating and cellular events in real time.

From Roche Sequencing and Life Science 29 Sep 2010

KINAXO, Daiichi Sankyo enter long-term partnership in cancer research

KINAXO Biotechnologies GmbH and Daiichi Sankyo Company Limited entered a long-term partnership in cancer research. Under the agreement, Daiichi Sankyo will employ KINAXO's technology platform to support the development of Daiichi Sankyo's targeted cancer drugs.

29 Sep 2010

Researchers unveil mechanism of candida infections

More than half of all people are hosts to Candida albicans in their bodies. This species might be located on their skin or mucous membranes or in the intestines frequently without causing any symptoms. However, it can be dangerous to patients whose immunological system has been weakened such as after organ transplants or chemotherapy with cancer. Then, this fungus penetrates into deeper layers of tissue and uses the blood system to spread throughout the body. In Germany alone, several thousand people die from systemic candida infections every year.

29 Sep 2010

Technology News and Research

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent

Researchers primed to contribute next phase in search and discovery: Elsevier survey

Sysmex to supply medical hematology analyzers to USAMMA

Inability to access EMRs at time of need a prime concern among patients

New computer program to help young adults manage mental illness

ANDalyze sensor/Fluorimeter platform solution introduced in China and Australia

African-American lung cancer patients with EGFR mutation respond better to erlotinib therapy

Circulating tumor cells may be promising alternative for tumor biopsies

CAP cells produce high virus titers upon influenza strain infection

Crescendo Biologics successfully delivers triple knockout mice

BAC completes feasibility study on CaptureSelect affinity ligands for Genmab

Scientists develop NIA assay to determine drug's differential effects in tumor cells

New RTCA Cardio Instrument monitors real-time cardiomyocyte beating and cellular events

KINAXO, Daiichi Sankyo enter long-term partnership in cancer research

Researchers unveil mechanism of candida infections

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News